The first intranasal Covid vaccination will be introduced in India on January 26.
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its type in India, on January 26, the company’s chairman and managing director Krishna Ella announced on Saturday.
Ella stated, while interacting with kids at the India International Science Festival in Bhopal, that the Lumpi-ProVacInd vaccine for the lumpy skin condition in cattle will likely be released next month.
“Our nasal vaccination will be officially launched on January 26, on Republic Day,” Ella remarked during the ‘Face-to-Face with New Frontiers in Science’ portion of the IISF, held at the Maulana Azad National Institute of Technology (MANIT).
In December, Bharat Biotech had announced that it will sell the intranasal vaccine for Rs 325 per shot for purchase by the government and Rs 800 per shot for commercial immunisation clinics.
